EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study

Fawaz H Tawhari iD, Mohammad F Zaitoun, Ehab Elmongui, Arwa Alhuwail, Ali Najmi, Wasayef M Alqahtani, Zeyad H Sabey, Atheer Almohammed, Abdulrahman Al Qahtani, Hani Sultan, Ahmed R N Ibrahim, Sultan Alshahrani und 1 weitere

Journal of Cardiovascular Pharmacology and Therapeutics · 2026-03 · 31

DOI: 10.1177/10742484261433147 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 16.03.2026. Verfasst von Fawaz H Tawhari und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacutical Care Administration, Armed Forces Hospital Southern Region, Ministry of Defense Health Services, Khamis Mushait, Saudi Arabia. Hauptthemen laut MEDLINE: Ventricular Remodeling, Acute Coronary Syndrome, Clopidogrel, Ticagrelor. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deanship of Scientific Research, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute coronary syndrome (ACS) remains a leading cause of mortality globally. Dual antiplatelet therapy (DAPT) is standard after percutaneous coronary intervention (PCI). While ticagrelor has demonstrated favorable myocardial effects in preclinical studies, limited clinical data compared its impact on left ventricular (LV) remodeling versus clopidogrel.

Objective

To evaluate and compare the effect of ticagrelor and clopidogrel on LV remodeling among ACS patients post-PCI.

Methods

Eligible participants were adults (≥18 years) with confirmed ACS who were prescribed ticagrelor or clopidogrel for at least 3 months after PCI and had complete echocardiographic data at baseline and within one-year follow-up. Patients with missing follow-up imaging, switching between antiplatelets, contraindications to DAPT, or noncompliance were excluded. Echocardiographic parameters—LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), LV ejection fraction (LVEF)—and B-type natriuretic peptide (BNP) were assessed, and multivariable regression models adjusted for confounders.

Results

A total of 137 patients met criteria (87 on ticagrelor, 50 on clopidogrel). Ticagrelor was associated with an adjusted LVEDV reduction of 8.17 mL compared with clopidogrel (95% CI −15.84 to −0.50; P = .039), an LVESV reduction of 8.09 mL (95% CI −13.88 to −2.29; P = .007), and a greater LVEF improvement of 4.05% (95% CI 2.41-5.70; P < .001). The reduction in BNP was also greater with ticagrelor by 73.56 pg/mL (95% CI −144.08 to −3.05; P = .043).

Conclusion

Ticagrelor was associated with more favorable LV remodeling parameters compared with clopidogrel in this cohort. These findings warrant confirmation in randomized trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular RemodelingAcute Coronary SyndromeClopidogrelTicagrelorPlatelet Aggregation InhibitorsVentricular Function, LeftPercutaneous Coronary InterventionPurinergic P2Y Receptor AntagonistsHumansAgedTreatment OutcomeFemaleRetrospective StudiesMaleMiddle AgedTime Factors

Stichwörter der Autor:innen

acute coronary syndromeclopidogrelleft ventricular remodelingpercutaneous coronary interventionticagrelor

Substanzen

ClopidogrelTicagrelorPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Pharmacutical Care Administration, Armed Forces Hospital Southern Region, Ministry of Defense Health Services, Khamis Mushait, Saudi Arabia.
  • Pharmacutical Care Department, Diaverum Saudi Arabia, Riyadh, Saudi Arabia.
  • Independent Researcher, Alexandria, Egypt.
  • Pharmacy Department, Saudi German Hospital, Khamis Mushait, Saudi Arabia.
  • Cardiology Department, Riyadh Second Health Cluster, King Fahad Medical City, Riyadh, Saudi Arabia.
  • College of Pharmacy, King Khalid University, Abha, Saudi Arabia.

ORCID-Profile: Fawaz H Tawhari, Reem Bahmaid

Förderung

  • Deanship of Scientific Research, King Khalid University

Zitieren

APA

Tawhari, F. H., Zaitoun, M. F., Elmongui, E., Alhuwail, A., Najmi, A., Alqahtani, W. M., Sabey, Z. H., Almohammed, A., Al Qahtani, A., Sultan, H., Ibrahim, A. R. N., Alshahrani, S., & Bahmaid, R. (2026). Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study. Journal of Cardiovascular Pharmacology and Therapeutics, 31. https://doi.org/10.1177/10742484261433147

Vancouver

Tawhari FH, Zaitoun MF, Elmongui E, Alhuwail A, Najmi A, Alqahtani WM, et al. Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study. Journal of Cardiovascular Pharmacology and Therapeutics. 2026;31. doi:10.1177/10742484261433147

BibTeX
@article{Tawhari2026,
  author = {Tawhari, Fawaz H and Zaitoun, Mohammad F and Elmongui, Ehab and Alhuwail, Arwa and Najmi, Ali and Alqahtani, Wasayef M and Sabey, Zeyad H and Almohammed, Atheer and Al Qahtani, Abdulrahman and Sultan, Hani and Ibrahim, Ahmed R N and Alshahrani, Sultan and Bahmaid, Reem},
  title = {Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2026},
  volume = {31},
  doi = {10.1177/10742484261433147}
}
Kostenlos starten →